448 related articles for article (PubMed ID: 29641567)
1. Use of capillary Western immunoassay (Wes) for quantification of dystrophin levels in skeletal muscle of healthy controls and individuals with Becker and Duchenne muscular dystrophy.
Beekman C; Janson AA; Baghat A; van Deutekom JC; Datson NA
PLoS One; 2018; 13(4):e0195850. PubMed ID: 29641567
[TBL] [Abstract][Full Text] [Related]
2. Low dystrophin variability between muscles and stable expression over time in Becker muscular dystrophy using capillary Western immunoassay.
Koeks Z; Janson AA; Beekman C; Signorelli M; van Duyvenvoorde HA; van den Bergen JC; Hooijmans MT; Alleman I; Hegeman IM; Verschuuren JJGM; V Deutekom JC; Spitali P; Datson NA; Niks EH
Sci Rep; 2021 Mar; 11(1):5952. PubMed ID: 33723284
[TBL] [Abstract][Full Text] [Related]
3. Development and Validation of a Western Blot Method to Quantify Mini-Dystrophin in Human Skeletal Muscle Biopsies.
Soderstrom CI; Larsen J; Owen C; Gifondorwa D; Beidler D; Yong FH; Conrad P; Neubert H; Moore SA; Hassanein M
AAPS J; 2022 Dec; 25(1):12. PubMed ID: 36539515
[TBL] [Abstract][Full Text] [Related]
4. Duchenne and Becker Muscular Dystrophies: A Review of Animal Models, Clinical End Points, and Biomarker Quantification.
Wilson K; Faelan C; Patterson-Kane JC; Rudmann DG; Moore SA; Frank D; Charleston J; Tinsley J; Young GD; Milici AJ
Toxicol Pathol; 2017 Oct; 45(7):961-976. PubMed ID: 28974147
[TBL] [Abstract][Full Text] [Related]
5. A novel high-throughput immunofluorescence analysis method for quantifying dystrophin intensity in entire transverse sections of Duchenne muscular dystrophy muscle biopsy samples.
Sardone V; Ellis M; Torelli S; Feng L; Chambers D; Eastwood D; Sewry C; Phadke R; Morgan JE; Muntoni F
PLoS One; 2018; 13(3):e0194540. PubMed ID: 29579078
[TBL] [Abstract][Full Text] [Related]
6. Systemic deletion of
Stirm M; Shashikadze B; Blutke A; Kemter E; Lange A; Stöckl JB; Jaudas F; Laane L; Kurome M; Keßler B; Zakhartchenko V; Bähr A; Klymiuk N; Nagashima H; Walter MC; Wurst W; Kupatt C; Fröhlich T; Wolf E
Proc Natl Acad Sci U S A; 2023 Jul; 120(29):e2301250120. PubMed ID: 37428903
[TBL] [Abstract][Full Text] [Related]
7. Tracking disease progression non-invasively in Duchenne and Becker muscular dystrophies.
Spitali P; Hettne K; Tsonaka R; Charrout M; van den Bergen J; Koeks Z; Kan HE; Hooijmans MT; Roos A; Straub V; Muntoni F; Al-Khalili-Szigyarto C; Koel-Simmelink MJA; Teunissen CE; Lochmüller H; Niks EH; Aartsma-Rus A
J Cachexia Sarcopenia Muscle; 2018 Aug; 9(4):715-726. PubMed ID: 29682908
[TBL] [Abstract][Full Text] [Related]
8. Accurate Dystrophin Quantification in Mouse Tissue; Identification of New and Evaluation of Existing Methods.
Hulsker M; Verhaart I; van Vliet L; Aartsma-Rus A; van Putten M
J Neuromuscul Dis; 2016 Mar; 3(1):77-90. PubMed ID: 27854205
[TBL] [Abstract][Full Text] [Related]
9. [From gene to disease; the dystrophin gene involved in Duchenne and Becker muscular dystrophy].
den Dunnen JT; de Visser M; Bakker E
Ned Tijdschr Geneeskd; 2002 Feb; 146(8):364-7. PubMed ID: 11887623
[TBL] [Abstract][Full Text] [Related]
10. A sensitive, reproducible and objective immunofluorescence analysis method of dystrophin in individual fibers in samples from patients with duchenne muscular dystrophy.
Beekman C; Sipkens JA; Testerink J; Giannakopoulos S; Kreuger D; van Deutekom JC; Campion GV; de Kimpe SJ; Lourbakos A
PLoS One; 2014; 9(9):e107494. PubMed ID: 25244123
[TBL] [Abstract][Full Text] [Related]
11. Quantification of dystrophin immunofluorescence in dystrophinopathy muscle specimens.
Taylor LE; Kaminoh YJ; Rodesch CK; Flanigan KM
Neuropathol Appl Neurobiol; 2012 Oct; 38(6):591-601. PubMed ID: 22243335
[TBL] [Abstract][Full Text] [Related]
12. Repression of phosphatidylinositol transfer protein α ameliorates the pathology of Duchenne muscular dystrophy.
Vieira NM; Spinazzola JM; Alexander MS; Moreira YB; Kawahara G; Gibbs DE; Mead LC; Verjovski-Almeida S; Zatz M; Kunkel LM
Proc Natl Acad Sci U S A; 2017 Jun; 114(23):6080-6085. PubMed ID: 28533404
[TBL] [Abstract][Full Text] [Related]
13. Report of a TREAT-NMD/World Duchenne Organisation Meeting on Dystrophin Quantification Methodology.
Aartsma-Rus A; Morgan J; Lonkar P; Neubert H; Owens J; Binks M; Montolio M; Phadke R; Datson N; Van Deutekom J; Morris GE; Rao VA; Hoffman EP; Muntoni F; Arechavala-Gomeza V;
J Neuromuscul Dis; 2019; 6(1):147-159. PubMed ID: 30614809
[TBL] [Abstract][Full Text] [Related]
14. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
[TBL] [Abstract][Full Text] [Related]
15. Clinical characterisation of Becker muscular dystrophy patients predicts favourable outcome in exon-skipping therapy.
van den Bergen JC; Schade van Westrum SM; Dekker L; van der Kooi AJ; de Visser M; Wokke BH; Straathof CS; Hulsker MA; Aartsma-Rus A; Verschuuren JJ; Ginjaar HB
J Neurol Neurosurg Psychiatry; 2014 Jan; 85(1):92-8. PubMed ID: 23667215
[TBL] [Abstract][Full Text] [Related]
16. Very Low Residual Dystrophin Quantity Is Associated with Milder Dystrophinopathy.
de Feraudy Y; Ben Yaou R; Wahbi K; Stalens C; Stantzou A; Laugel V; Desguerre I; ; Servais L; Leturcq F; Amthor H
Ann Neurol; 2021 Feb; 89(2):280-292. PubMed ID: 33159473
[TBL] [Abstract][Full Text] [Related]
17. Dystrophin analysis in carriers of Duchenne and Becker muscular dystrophy.
Hoogerwaard EM; Ginjaar IB; Bakker E; de Visser M
Neurology; 2005 Dec; 65(12):1984-6. PubMed ID: 16380627
[TBL] [Abstract][Full Text] [Related]
18. Skeletal Muscle Differentiation on a Chip Shows Human Donor Mesoangioblasts' Efficiency in Restoring Dystrophin in a Duchenne Muscular Dystrophy Model.
Serena E; Zatti S; Zoso A; Lo Verso F; Tedesco FS; Cossu G; Elvassore N
Stem Cells Transl Med; 2016 Dec; 5(12):1676-1683. PubMed ID: 27502519
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional and epigenetic analyses of the DMD locus reveal novel cis‑acting DNA elements that govern muscle dystrophin expression.
Gherardi S; Bovolenta M; Passarelli C; Falzarano MS; Pigini P; Scotton C; Neri M; Armaroli A; Osman H; Selvatici R; Gualandi F; Recchia A; Mora M; Bernasconi P; Maggi L; Morandi L; Ferlini A; Perini G
Biochim Biophys Acta Gene Regul Mech; 2017 Nov; 1860(11):1138-1147. PubMed ID: 28867298
[TBL] [Abstract][Full Text] [Related]
20. Myoblots: dystrophin quantification by in-cell western assay for a streamlined development of Duchenne muscular dystrophy (DMD) treatments.
Ruiz-Del-Yerro E; Garcia-Jimenez I; Mamchaoui K; Arechavala-Gomeza V
Neuropathol Appl Neurobiol; 2018 Aug; 44(5):463-473. PubMed ID: 29086434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
